Distinct roles for CD28 and cytotoxic T lymphocyte-associated molecule-4 receptors during T cell activation?
Open Access
- 1 August 1995
- journal article
- review article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 182 (2), 289-292
- https://doi.org/10.1084/jem.182.2.289
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Treatment of Murine Lupus with CTLA4IgScience, 1994
- The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3'-kinase.Molecular and Cellular Biology, 1994
- Two-step TCRζ/CD3-CD4 and CD28 signaling in T cells: SH2/SH3 domains, protein-tyrosine and lipid kinasesImmunology Today, 1994
- Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7.The Journal of Immunology, 1994
- Costimulation of T cells for tumor immunityImmunology Today, 1993
- Differential T Cell Costimulatory Requirements in CD28-Deficient MiceScience, 1993
- CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production.The Journal of Immunology, 1992
- Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapyCell, 1992
- Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.The Journal of Experimental Medicine, 1992
- CTLA-4 is a second receptor for the B cell activation antigen B7.The Journal of Experimental Medicine, 1991